1. (A) Distribution of CsA nephrotoxicity lesions according to antihypertensive treatment and CsA C2 levels.
(A) Distribution of CsA nephrotoxicity lesions according to antihypertensive treatment and CsA C2 levels. Circles are filled to indicate the presence of CsA nephrotoxicity as indicated in the legend. cPatients with combined treatment with calcium channel blocker (CCB) and angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB). (B) Odds ratios for the development of overt CsA toxicity. The population was divided using various cutoffs of CsA C2 levels. CsA C2 levels were calculated for each patient as the average of all levels measured during a period of 2 yr before each biopsy. Odds ratios are adjusted for the use of ACEIs or ARBs. Horizontal bars indicate low and high 95% confidence intervals. *P < 0.03.
Severin-Wafo Kengne et al. CJASN 2009;4:
©2009 by American Society of Nephrology